Trial Profile
Postmarketing Surveillance of Tocilizumab to Evaluate Efficacy and Safety in Japanese patients with Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 17 Nov 2015 New trial record